Validation of the use of a fluorescent PARP1 inhibitor for the detection of oral, oropharyngeal and oesophageal epithelial cancers.
Kossatz S, Pirovano G, Demétrio De Souza França P, Strome AL, Sunny SP, Zanoni DK, Mauguen A, Carney B, Brand C, Shah V, Ramanajinappa RD, Hedne N, Birur P, Sihag S, Ghossein RA, Gönen M, Strome M, Suresh A, Molena D, Ganly I, Kuriakose MA, Patel SG, Reiner T.
Kossatz S, et al. Among authors: hedne n.
Nat Biomed Eng. 2020 Mar;4(3):272-285. doi: 10.1038/s41551-020-0526-9. Epub 2020 Mar 12.
Nat Biomed Eng. 2020.
PMID: 32165735
Free PMC article.